Table 2.

Median values (Q1-Q3) of expression of selected miRNAs infected with EBV with hepatological complications (IA, IB) and from the control group (II)

Expression (log10)	Group IA n= 33	Group IB n= 21	Group II n= 14	P value IA vs. II	P value IB vs. II
miR-21-3p	0.8 (0.6-1.0)	0.8 (0.6-0.9)	0.5 (0.4-0.7)	0.002	0.556
miR-122-5p	–3.3 (–3.9 to –2.9)	–4.8 (–5.2 to –4.26)	–5.4 (–5.7 to –4.1)	< 0.001	0.047
miR-26b-5p	–0.7 (–0.8 to –0.2)	–1.0 (–1.1 to –0.78)	–0.9 (–1.3 to –0.7)	< 0.001	0.649
miR-34a-5p	–2.9 (–3.3 to –1.8)	–3.4 (–4.5 to –3.1)	–3.9 (–4.8 to –3.1)	0.003	0.419
miR-199a-5p	–1.9 (–2.3 to –1.5)	–2.4 (–2.7 to –2.1)	–2.5 (–2.8 to –2.2)	< 0.001	0.439

IA – group with increased ALT and GGTP activity, IB – group with increased ALT and normal GGTP activity, II – control group with normal ALT and GGTP activity